Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D 2

Psychopharmacology

Volumn 210, Issue 3, 2010, Pages 331-336

  Sekine, Mizuho ^a,b   Arakawa, Ryosuke ^a,b   Ito, Hiroshi ^a   Okumura, Masaki ^a,b   Sasaki, Takeshi ^a   Takahashi, Hidehiko ^a   Takano, Harumasa ^a   Okubo, Yoshiro ^b   Halldin, Christer ^c   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

(S,S) 18F FMeNER D 2; Norepinephrine transporter; Nortriptyline; Occupancy; Positron emission tomography

Indexed keywords

NORADRENALIN TRANSPORTER; NORTRIPTYLINE;

ADULT; ARTICLE; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE DRUG DOSE; THALAMUS;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORINE RADIOISOTOPES; HUMANS; MALE; MORPHOLINES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; NORTRIPTYLINE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; YOUNG ADULT;

EID: 77955577916     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1824-9     Document Type: Article

References (35)

1. Arakawa R, Okumura M, Ito H, Seki C, Takahashi H, Takano H, Nakao R, Suzuki K, Okubo Y, Halldin C, Suhara T (2008) Quantitative analysis of norepinephrine transporter in the human brain using PET with (S, S)-[18F]FMeNER-D2. J Nucl Med 49:1270-1276
2. Asberg M, Cronholm B, Sjoqvist F, Tuck D (1971) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3:331-334
3. Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RK (2010) Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab 30:46-50
4. De Wilde JE, Mertens C, Wakelin JS (1983) Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing. Br J Clin Pharmacol 15 (Suppl 3):427S-431S
5. Dick P, Ferrero E (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. Br J Clin Pharmacol 15 (Suppl 3):419S-425S
6. 3H] mazindol autoradiography. J Comp Neurol 304:419-434
7. Guelfi JD, Dreyfus JF, Pichot P (1987) Fluvoxamine and imipramine: results of a long-term controlled trial. Int Clin Psychopharmacol 2:103-109
8. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
9. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112
10. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539
11. 11C]raclopride binding. J Cereb Blood Flow Metab 18:941-950
12. Kampf-Sherf O, Zlotogorski Z, Gilboa A, Speedie L, Lereya J, Rosca P, Shavit Y (2004) Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants. J Affect Disord 82:453-459
13. Kragh-Sorensen P, Hansen CE, Baastrup PC, Hvidberg EF (1976) Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. Psychopharmacologia 45:305-312
14. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158
15. Logan J, Wang GJ, Telang F, Fowler JS, Alexoff D, Zabroski J, Jayne M, Hubbard B, King P, Carter P, Shea C, Xu Y, Muench L, Schlyer D, Learned-Coughlin S, Cosson V, Volkow ND, Ding YS (2007) Imaging the norepinephrine transporter in humans with (S, S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol 34:667-679
16. Martin AJ, Tebbs VM, Ashford JJ (1987) Affective disorders in general practice. Treatment of 6000 patients with fluvoxamine. Pharmatherapeutica 5:40-49
17. 11C] DASB PET imaging study. Am J Psychiatry 158:1843-1849
18. 11C]DASB positron emission tomography study. Am J Psychiatry 161:826-835
19. Nordin C, Bertilsson L, Dahl ML, Resul B, Toresson G, Sjoqvist F (1991) Treatment of depression with E-10-hydroxynortriptyline-a pilot study on biochemical effects and pharmacokinetics. Psychopharmacology (Berl) 103:287-290
20. Nutt DJ (2006) The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 67 (Suppl 6):3-8
21. Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC (2007) Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 62:1217-1227
22. Sadock B, Sadock V (2007) Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. Lippincott Williams & Wilkins, Philadelphia
23. Schou M, Halldin C, Sovago J, Pike VW, Hall H, Gulyas B, Mozley PD, Dobson D, Shchukin E, Innis RB, Farde L (2004) PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 53:57-67
24. Schou M, Halldin C, Pike VW, Mozley PD, Dobson D, Innis RB, Farde L, Hall H (2005) Post-mortem human brain autoradiography of the norepinephrine transporter using (S, S)-[18F] FMeNER-D2. Eur Neuropsychopharmacol 15:517-520
25. Seneca N, Gulyas B, Varrone A, Schou M, Airaksinen A, Tauscher J, Vandenhende F, Kielbasa W, Farde L, Innis RB, Halldin C (2006) Atomoxetine occupies the norepinephrine transporter in a dosedependent fashion: a PET study in nonhuman primate brain using (S, S)-[18F]FMeNER-D2. Psychopharmacology (Berl) 188:119-127
26. Southwick SM, Davis M, Horner B, Cahill L, Morgan CA 3rd, Gold PE, Bremner JD, Charney DC (2002) Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Am J Psychiatry 159:1420-1422
27. Stokes PE (1993) Fluoxetine: a five-year review. Clin Ther 15:216-243, discussion 215
28. Strange BA, Hurlemann R, Dolan RJ (2003) An emotion-induced retrograde amnesia in humans is amygdala-and beta-adrenergicdependent. Proc Natl Acad Sci U S A 100:13626-13631
29. Suhara T, Takano A, Sudo Y, Ichimiya T, Inoue M, Yasuno F, Ikoma Y, Okubo Y (2003) High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry 60:386-391
30. Takano A, Suzuki K, Kosaka J, Ota M, Nozaki S, Ikoma Y, Tanada S, Suhara T (2006) A dose-finding study of duloxetine based on serotonin transporter occupancy. Psychopharmacology (Berl) 185:395-399
31. Takano A, Gulyas B, Varrone A, Karlsson P, Schou M, Airaksinen AJ, Vandenhende F, Tauscher J, Halldin C (2008a) Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S, S)-[18F]FMeNER-D2. Eur J Nucl Med Mol Imaging 35:153-157
32. Takano A, Varrone A, Gulyas B, Karlsson P, Tauscher J, Halldin C (2008b) Mapping of the norepinephrine transporter in the human brain using PET with (S, S)-[18F]FMeNER-D2. Neuroimage 42:474-482
33. Takano A, Gulyas B, Varrone A, Maguire RP, Halldin C (2009) Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S, S)-[18F]FMeNER-D2. Eur J Nucl Med Mol Imaging 36:1308-1314
34. Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ (2007) Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J Clin Psychopharmacol 27:672-676
35. Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ (2004) Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry 55:320-322